Elevated Doublecortin-Like Kinase 1 Serum Levels Revert to Baseline After Therapy in Early Stage Esophageal Adenocarcinoma

Biomarker Research - United Kingdom
doi 10.1186/s40364-019-0157-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Elevated Baseline CA19-9 Levels Correlate With Adverse Prognosis in Patients With Early- Or Advanced-Stage Pancreas Cancer

Medical Oncology
MedicineCancer ResearchOncologyHematology
2012English

Serum Creatine Kinase Levels.

BMJ
1970English

Alternative Splice Variants of Doublecortin-Like Kinase Are Differentially Expressed and Have Different Kinase Activities

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Serum Myostatin Levels Are Elevated in Overweight Patients

The Open Obesity Journal
2014English

A Complete Response to S-1 Plus Cis-Diamminedichloroplatinum in Advanced-Stage Esophageal and Gastric Adenocarcinoma: A Case Report

World Journal of Surgical Oncology
SurgeryOncology
2012English

Molecular Prognostic Factors in Early-Stage Cervical Adenocarcinoma

Polish Journal of Pathology
MedicineForensic MedicinePathology
2018English

Vitamin D Receptor Expression and Neoadjuvant Therapy in Esophageal Adenocarcinoma

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2012English

Elevated Levels of Serum Urokinase Plasminogen Activator Predict Poor Prognosis in Hepatocellular Carcinoma After Resection

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy